Drug Approval | December 06, 2023
Granules India received ANDA approval for Sildenafil for oral suspension
The current annual U.S. market for Sildenafil for Oral Suspension is approximately $43 million
The current annual U.S. market for Sildenafil for Oral Suspension is approximately $43 million
Sales in the US region grew well, partially offset by the decline in the LATAM and European regions
Short-term treatment of heartburn and other symptoms associated with gastroesophageal reflux disease (GERD)
Granules India received approval from Brazilian Health Regulatory Agency ANVISA
API, PFI, and Finished dosages contribute 30%, 15%, and 55% of revenue from operations respectively for Q1FY24
The inspection was conducted at Granules Pharmaceuticals Inc. (GPI) from July 31, 2023 to August 03, 2023
This product will be launched through Granules Consumer Health (GCH) division
The zero-observation outcome reflects the company's robust quality management systems and commitment to excellence in its operations.
Granules India sponsored an initiative to ignite a drug-free revolution and contribute towards an empowered society
Metoprolol Succinate ER Tablets are indicated for the treatment of hypertension in order to lower blood pressure.
Subscribe To Our Newsletter & Stay Updated
